Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Brandel

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|August 30, 2000
MRI and the second French case of vCJDC Oppenheim, J P Brandel, J J Hauw, et al.
Neuroscience Letters|May 29, 2000
First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseasesK Peoc'h, C Guérin, J P Brandel, et al.
Journal of Neurochemistry|February 1, 1991
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysisE C Hirsch, J P Brandel, P Galle, et al.
Revue Neurologique|January 1, 1988
[Alzheimer's disease with early association of a hemi-parkinsonian syndrome]B Lechevalier, J P Brandel, F Eustache, et al.
AJNR. American Journal of Neuroradiology|March 29, 2008
Differences of apparent diffusion coefficient values in patients with Creutzfeldt-Jakob disease according to the codon 129 genotypeD Galanaud, D Dormont, S Haïk, et al.
Neuroscience|January 1, 1991
Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsyJ P Brandel, E C Hirsch, S Malessa, et al.
Neurology|March 17, 2000
Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimatesJ P Brandel, N Delasnerie-Lauprêtre, J L Laplanche, et al.
Annales De Cardiologie Et D'Angeiologie|July 1, 1985
[Ectasia of coronary arteries. Review of the literature. Apropos of 5 cases]P Commeau, C Breut, G Grollier, et al.
Revue Neurologique|May 27, 2026
Six-month outcomes of subcutaneous foslevodopa/foscarbidopa according to initiation setting in advanced Parkinson's disease: A retrospective cohort studyC Desjardins, H de Saint Vaulry, C Rosset, et al.
Annals of Neurology|February 28, 2001
14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patientsJ P Brandel, K Peoc'h, P Beaudry, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|August 30, 2000
MRI and the second French case of vCJDC Oppenheim, J P Brandel, J J Hauw, et al.
Neuroscience Letters|May 29, 2000
First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseasesK Peoc'h, C Guérin, J P Brandel, et al.
Journal of Neurochemistry|February 1, 1991
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysisE C Hirsch, J P Brandel, P Galle, et al.
Revue Neurologique|January 1, 1988
[Alzheimer's disease with early association of a hemi-parkinsonian syndrome]B Lechevalier, J P Brandel, F Eustache, et al.
AJNR. American Journal of Neuroradiology|March 29, 2008
Differences of apparent diffusion coefficient values in patients with Creutzfeldt-Jakob disease according to the codon 129 genotypeD Galanaud, D Dormont, S Haïk, et al.
Neuroscience|January 1, 1991
Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsyJ P Brandel, E C Hirsch, S Malessa, et al.
Neurology|March 17, 2000
Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimatesJ P Brandel, N Delasnerie-Lauprêtre, J L Laplanche, et al.
Annales De Cardiologie Et D'Angeiologie|July 1, 1985
[Ectasia of coronary arteries. Review of the literature. Apropos of 5 cases]P Commeau, C Breut, G Grollier, et al.
Revue Neurologique|May 27, 2026
Six-month outcomes of subcutaneous foslevodopa/foscarbidopa according to initiation setting in advanced Parkinson's disease: A retrospective cohort studyC Desjardins, H de Saint Vaulry, C Rosset, et al.
Annals of Neurology|February 28, 2001
14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patientsJ P Brandel, K Peoc'h, P Beaudry, et al.
Pageof 8